Related Experiment Video
Updated: Aug 6, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
[Treatment of obstructive aortic atheroma in homozygotic familial hypercholesterolemia]
1Service de Chirurgie Thoracique et Cardiovasculaire, Hôpital La Pitié-Salpêtrière, Paris.
Insights
This report details a surgical approach for homozygotic familial hypercholesterolaemia (HFH) involving aortic valve, ascending aorta, and coronary ostia. The single-procedure surgery successfully corrected all abnormalities in three patients, showing favorable outcomes.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Metabolic Disorders
Context:
- Homozygotic familial hypercholesterolaemia (HFH) is a rare genetic disorder.
- HFH can manifest with severe cardiovascular complications, including valvular and coronary artery stenosis.
- This specific HFH phenotype involves aortic valve, ascending aorta, and coronary ostia.
Purpose:
- To describe a surgical technique for treating a rare form of HFH.
- To detail the correction of combined valvular, supravalvular, and coronary ostial stenosis in HFH patients.
- To report the outcomes of a multi-component surgical intervention for complex HFH.
Summary:
- Three HFH patients with left ventricular ejection obstruction and myocardial ischemia underwent a single-procedure surgery.
- The surgery included aortic valve replacement, ascending aortic replacement, and coronary ostia widening with reimplantation.
- Postoperative results were favorable, with normalized cardiac function and unobstructed coronary arteries.
Impact:
- The described surgical strategy offers a comprehensive solution for complex HFH cardiovascular manifestations.
- This approach aims for good long-term results in patients with severe, multi-site aortic and coronary disease.
- Highlights the importance of addressing all affected cardiovascular structures in this rare HFH variant.
Abstract:
The object of this report is to describe the surgical treatment of a rare clinical form of homozygotic familial hypercholesterolaemia (HFH) associating valvular and supravalvular stenosis with coronary ostial stenosis. Three patients, two male and one female, aged 15, 23 and 41 respectively, suffering from HFH diagnosed in early childhood, presented with obstacles to left ventricular ejection and myocardial ischaemia due to coronary ostial stenosis. Surgery consisted of corrections in a single procedure of all abnormalities by aortic valve replacement, ascending aortic replacement and widening of the coronary artery ostia which were reimplanted on the aortic tube. The postoperative course of all three patients was favourable. Postoperative echocardiography showed the normal position of the valvular prosthesis, normalisation of the left ventricular ejection fraction with no significant residual obstruction. Angioscan of the coronary arteries showed a good result of coronary ostial widening. The authors conclude that HFH is a rare condition and that disease of the ascending aorta is common in this variety with involvement of the aortic valve, the ascending aorta and the coronary ostia. The surgical procedure described by the authors allows correction of all the abnormalities with the hope of a good long-term result.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...